Federal court of appeal strikes claim for extending patent term.
In a short October 1999 decision, Pfizer Inc v Canada, the Federal Court of Appeal affirmed a lower court decision that Canadian law currently provides only 17 years protection for drug patents filed before October 1989, and that the 20-year minimum period stated in intellectual property treaties negotiated under the auspices of the World Trade Organization have not (yet) taken effect in Canada with respect to these drugs.
Elliott
R
R
D019380:Anti-HIV Agents; D002170:Canada; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*
D019380:Anti-HIV Agents